Princeton Junction, NJ, United States of America

Shekar Srinivas


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:

goldMedal1 out of 832,843 
Other
 patents

Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shekar Srinivas: Innovator in Th2-Associated Disease Treatment

Introduction

Shekar Srinivas is a notable inventor based in Princeton Junction, NJ (US). He has made significant contributions to the field of medical treatment, particularly in addressing Th2-associated diseases and disorders. His innovative approach utilizes interferon lambda (IFN-λ) to modulate the expression or secretion of key interleukins.

Latest Patents

Srinivas holds a patent for the invention titled "Ex-vivo treatment of peripheral blood leukocytes with IFN-λ." This patent outlines a method for treating Th2-associated diseases by treating a patient's cells ex vivo with IFN-λ before returning them to the patient. The invention aims to improve the management of conditions linked to Th2 responses by effectively modulating the immune response.

Career Highlights

Throughout his career, Shekar Srinivas has demonstrated a commitment to advancing medical science. His work has led to the development of innovative treatment methods that have the potential to significantly impact patient care. With 1 patent to his name, he continues to explore new avenues in medical research.

Collaborations

Srinivas has collaborated with esteemed colleagues, including Grant E Gallagher and Joyce Eskdale. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of medical innovation.

Conclusion

Shekar Srinivas is a pioneering inventor whose work in the treatment of Th2-associated diseases showcases the potential of innovative medical therapies. His contributions to the field are invaluable, and his ongoing research promises to enhance patient outcomes in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…